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SUMMARY 
The aim of this work is to study the risk of obesity posed by two genetic factors: 
haptoglobin phenotype and acid phosphatase phenotype, one enzymatic activity: acid 
phosphatase activity (ACP1), age and gender.  
Haptoglobin (Hp) is a protein of the immune system, and three phenotypes of Hp are 
found in humans: Hp1-1, Hp2-1, and Hp2-2. This protein is associated with a 
susceptibility to common pathological conditions, such as obesity. ACP1 is an 
intracellular enzyme The phenotypes of ACP1 (AA, AB, AC, BB, BC, CC) are also 
considered. 
We took a sample of 127 subjects with complete data from 714 registers. Since we 
intend to identify risk factors for obesity, an ordinal regression model is adjusted, using 
the Body Mass Index, BMI, to define weight categories. Haptoglobin phenotype, 
enzymatic activity of ACP1, acid phosphatase phenotype, age and gender are considered 
as regressor variables. 
We found three factors associated with an increased risk of obesity: phenotype Hp2-1 of 
haptoglobin (estimated odds ratio OR  11.54), phenotype AA of acid phosphatase ( OR  
33.788) and age ( OR  1.39). The interaction between phenotype Hp2-1 and phenotype 
AC is associated with a decreased risk of obesity ( OR  0.032); The interaction between 
phenotype AA and ACP1 activity is associated with a decreased risk of obesity ( OR  
0.954). 












Obesity is currently a serious problem of public health, so it is relevant to 
design research in order to identify individual characteristics that may be risk 
factors, and to establish some prevention strategies. It is known from previous 
studies that there are some genetic factors related associated with a 
predisposition to obesity.  
The Body Mass Index (BMI) provides an indicator of body fatness, and 
according to the World Health Organization it enables classification in four 
categories of weight (underweight, normal weight, excess weight and obese). 
In this work we study some potential risk factors, namely: two genetic 
factors, haptoglobin phenotypes and acid phosphatase phenotypes; one 
particular enzymatic activity: acid phosphatase activity; and demographic 
factors, such as age (between 18 and 98 years) and gender.  
Haptoglobin (Hp) is a protein of the immune system. Hp exists in two allelic 
forms in the human population, called Hp1 and Hp2, the latter having arisen due 
to partial duplication of the Hp1 gene. Three phenotypes of Hp are therefore 
found in humans: Hp1-1, Hp2-1 and Hp2-2. Hp of different genotypes has been 
shown to bind haemoglobin with different affinities, with Hp2-2 being the 
weakest binder. This protein is associated with susceptibility to common 
pathological conditions, such as obesity.  
The acid phosphatase ACP1 is an intracellular enzyme that has 
phosphotyrosine phosphatase and flavin-mononucleotide (FMN) phosphor-
transferase protein activity. The phenotypes of acid phosphatase are AA, AB, 
AC, BB, BC and CC. 
Considering weight categories (the response variable) as categories of an 
ordinal categorical variable, since there is a natural ordering of its possible 
values (underweight, normal weight, overweight and obese), an Ordinal Regre-
ssion Model was developed in order to predict the risk of obesity. As regressor 
variables, we consider the enzymatic activity of acid phosphatase (ACP1 
activity), acid phosphatase phenotype, haptoglobin phenotype, age and gender. 
The adjusted model analysis leads to the conclusion that some of the 
selected risk factors may be important in predicting obesity risk. At a 
significance level of 5%, the most significant results associated with an 












ratio OR  11.54; 95% confidence interval CI95%, (2.10; 21.74)), acid phospha-
tase phenotype AA ( OR  33.79; CI95% (7.73; 60.10)), and age ( OR 1.39; CI95% 
(1.15; 1.67)). The interaction between phenotype Hp2-1 and phenotype AC of 
acid phosphatase is associated with a decreased risk of obesity ( OR  0.032; 
CI95% (0.02; 0.11)) and the interaction between phenotype AA of acid 
phosphatase and the enzyme activity is also associated with a decreased risk of 
obesity ( OR  0.95; CI95% (0.92; 0.99)). 
2. Material and methods  
In this work we took a subset of 127 subjects from a database of 714 
subjects from the Genetics Laboratory of the Centre of Endocrinology and 
Metabolism at the University of Lisbon, with complete data for all variables 
chosen for this study. The subjects are men and women aged between 18 and 98 
years. 
The four categories of weight were coded as follows: 0 for underweight; 
1 for normal weight, 2 for excess weight, 3 for obese. 
The three phenotypes of haptoglobin (Hp) were coded as follows: 0 for 
Hp1-1, 1 for Hp2-1, 2 for Hp2-2.  
The acid phosphatase phenotypes were coded 0 for AA, 1 for AB, 2 for AC, 
3 for BB, 4 for BC and 5 for CC. 
The ordinal regression model is one of many models subsumed under the 
rubric of generalized linear models for ordinal data. The model is based on the 
assumption that there is a latent continuous outcome variable (BMI in the 
present study) and that the observed ordinal outcome arises from discretizing 
the underlying continuum into i-ordered groups (BMI categories, Y). The thres-
holds estimate these cut-off values. Thus we assume an ordinal regression 
model to predict the risk of obesity, considering as regressor variables 
haptoglobin phenotype (X1), acid phosphatase phenotype (X2), enzymatic 
activity of ACP1 (X3), age (X4) and gender (X5). The model included the 
interaction effects X1*X2, X2*X3, X3*X4, X4*X5. 
The Cauchit (inverse Cauchy) link function seems to be the most 
appropriate choice, since the outcome includes many extreme values.  
This link function is defined by 











where γi is the cumulative probability for the ith category, αi represents a 
separate intercept or threshold for each cumulative probability; β is the row 
vector of regression coefficients and X is the design matrix of the regressor 
variables. The threshold (αi) and the regression vector of coefficients (β) are 
unknown parameters to be estimated using the maximum likelihood method. 
Note that, in ordinal regression, the probability of an event is redefined in terms 
of cumulative probabilities.  
Thus the model equation is 
 
, i=0, 1, 2, 3.              (2) 
 
Some regressor variables are categorical with more then two categories, so 
it was necessary to create dummy variables for each one of these variables. For 
haptoglobin phenotype, two dummy variables were considered, namely 
 
, k=0, 1,            (3) 
 
being the reference category Hp2-2.  
For the acid phosphatase phenotype five dummy variables were defined, as 
follows:  
, j=0, 1, 2, 3, 4,     (4) 
 
being the reference category for the phenotype BC. 
According to this formulation, we have 
                                         (5)                      
 
 
To perform an overall test of the null hypothesis that all coefficients of the 
variables in the model are null, i.e. 0β =:0H , we used the change in 
-2logLikelihood when the variables are added to a model that contains only the 
( ) ( ) 5.0tan 1 +−=≤= −
pi

























































intercept. The change in likelihood function is distributed as a chi-square with 
p–1 degrees of freedom, where p is the number of coefficients in the model. 
To test the significance of individual coefficients, the Wald statistic was 
used, which under the null hypothesis is normally distributed. 
To compare the full model, including p variables, with the corresponding 
reduced model, excluding the q variables related to non-significant coefficients, 
we used the Likelihood ratio test. For this test we have: 
( ) ( )[ ]modelfullmodelreduced2 oodloglikelihoodloglikelihG −−=
 
Under the null hypothesis that the coefficients of the excluded variables are 
zero, the statistic G follows a chi-square distribution with p–q degrees of 
freedom. 
The statistical package SPSS 16.0 was used for the statistical data analysis. 
3. Results 
After the adjustment of the postulated model as formalized in equations (2) 
and (5), the goodness-of-fit statistic indicates that the model, henceforth called 
the full model, does not fit well (the chi-square statistic with 351 d.f. is 421.699, 
and the corresponding p-value=0.006<0.05). 
Given this results for the full model, we tried a reduced model, removing 
the regressor “gender” from the equation. The results of the goodness-of-fit tests 
lead to a good fit (the chi-square statistic with 352 d.f. is 386.295 and the 
corresponding p-value=0.101>0.05). 
Another way to assess the goodness of fit is to compare the percentage of 
subjects correctly classified by the model with the percentage of subjects 
correctly classified by chance. From the results of the cross-tabulation between 
observed weight categories and predicted response weight categories (Table 1), 
we observe that the model predicts correctly 52.2% of the Underweight 
category, 82.7% of the Normal Weight category, 66.7% of the Overweight 
category and 52.6% of the Obese category. 
In general the model classifies correctly 68.5% of the subjects. By 
comparison, the percentage of subjects correctly classified by chance is only 











The significance test of the model, based on the statistic G (equation 6), 
leads to the rejection of the null hypothesis that all coefficients of the variables 
in the model are zero (G = 234.173, p-value<0.05). 
 
Table 1. Results of cross tabulation between observed weight categories and predicted 
response weight categories. 
















52.2% 39.1% 4.3% 4.3% 100,0% 






5.8% 82.7% 11.5% .0% 100,0% 






0.0% 21.2% 66.7% 12.1% 100,0% 
















5.3% 15.8% 26.3% 52.6% 100,0% 






12.6% 48.8% 26.8% 11.8% 100.0% 
 
The parallel lines test was chosen to make a judgement concerning the 
model’s adequacy. The null hypothesis was that the corresponding regression 
coefficients were equal across all levels of the outcome variable. The chi-square 
test result (p-value>0.05) in this reduced model indicates that there are no 
significant differences for the corresponding regression coefficients across the 













The actual model proved to be the best when compared with other reduced 
models, since the Likelihood ratio test rejects the null hypothesis that the 
coefficients of the excluded variables are zero (p-value<0.05). 
The significance test of the model, based on the statistic G (equation 6), 
leads to the rejection of the null hypothesis that all coefficients of the variables 
in the model are zero (G = 234.173, p-value<0.05). 
Several R2-like statistics can be used to measure the strength of the 
association between the dependent variable and the predictor variables. 
However they are not as useful as the statistic in regression, since their 
interpretation is not straightforward. 

















   
where )ˆ(BL  is the log-likelihood function for the model with the estimated 
parameters, )( 0BL  is the log-likelihood with just the thresholds and n is the 
number of cases. In this case, the value of the pseudo R2 statistic is 0.539, the 
highest value we found among the considered set of significant and well-fitting 
models. 
At a significance level of 5%, the most significant results associated with an 
increased risk of obesity were (Table 2): phenotype Hp2-1 of haptoglobin – this 
gives a higher chance of obesity compared with the reference category Hp2-2 
( 54.11=OR ); phenotype AA of acid phosphatase – compared with the referen-
ce category (CC) it gives an almost 34 times greater probability of higher 
weight categories ( 79.33=OR ); the estimated odds ratio for age, 1.39, 
indicates that for every increase of ten years in age, the risk of belonging to a 
higher weight category increases 7.613 times. 
The interaction between phenotype Hp2-1 and phenotype AC of acid 
phosphatase is associated with a decreased risk of obesity ( 032.0=OR ). The 
interaction between phenotype AA of acid phosphatase and the activity of this 











Table 2. Parameter estimates, odds ratios and confidence interval estimates (Link 
function: Cauchit) 






















Threshold           
[under-
weight] 7.319 2.774 6.962 1 0.008 1.882 12.756    
[normal 
weight] 12.127 3.316 13.378 1 0.000 5.629 18.626    
[excess 
weight] 15.505 3.727 17.312 1 0.000 8.201 22.809    
Location           
[Hp1-1] 1.737 2.176 0.637 1 0.425 -2.527 6.000 5.013 0.136 18.024 
[Hp2-1] 3.908 1.676 5.440 1 0.020 0.624 7.192 11.542 2.102 21.741 
[Hp2-2] (a) . .  . . . (a) (a) (a) 
[AA] 11.043 4.279 6.660 1 0.010 2.656 19.430 33.788 7.725 60.095 
[AB] 3.249 2.671 1.479 1 0.224 -1.986 8.484 9.521 0.174 25.777 
[AC] 7.082 4.513 2.463 1 0.117 -1.763 15.928 21.397 0.197 49.105 
[BB] 0.901 2.690 0.112 1 0.738 -4.372 6.174 2.751 0.077 18.565 
[BC] 0.034 3.975 0.000 1 0.993 -7.757 7.826 1.045 0.043 23.718 
[CC] (a) . . 0 . . . (a) (a) (a) 
ACP1 
Activity 0.019 0.010 3.605 1 0.058 -0.001 0.040 1.025 0.999 1.052 
Age 0.262 0.078 11.378 1 0.001 0.110 0.414 1.390 1.150 1.666 
[Hp1-1] * 
[AA] 1.428 3.164 0.204 1 0.652 -4.774 7.631 4.144 0.070 23.109 
[Hp1-1] * 
[AB] -1.646 2.507 0.431 1 0.511 -6.559 3.267 0.210 0.051 9.575 
[Hp1-1] * 
[AC] -6.070 6.137 0.978 1 0.323 -18.098 5.958 0.055 0.018 17.891 
[Hp1-1] * 
[BB] -5.039 3.069 2.695 1 0.101 -11.054 0.977 0.067 0.030 2.941 
[Hp1-1] * 
[BC] 1.770 2.680 0.436 1 0.509 -3.483 7.024 5.110 0.098 21.214 
[Hp1-1] * 
[CC] (a) . . 0 . . . 
(a) (a) (a) 
[Hp2-1] * 
[AA] -4.433 2.392 3.434 1 0.064 -9.121 0.255 0.076 0.036 1.379 
[Hp2-1] * 
[AB] -0.746 1.646 0.205 1 0.650 -3.972 2.480 0.420 0.085 7.197 
[Hp2-1] * 
[AC] -10.246 3.612 8.046 1 0.005 -17.326 -3.166 0.032 0.019 0.108 
[Hp2-1] * 
[BB] -2.879 1.891 2.317 1 0.128 -6.586 0.828 0.119 0.050 2.573 
[Hp2-1] * 
[BC] -2.619 2.287 1.312 1 0.252 -7.102 1.863 0.131 0.047 5.377 
[Hp2-1] * 
[CC] (a) . .  . . . (a) (a) (a) 
[Hp2-2] * 
[AA] (a) . .  . . . (a) (a) (a) 
[Hp2-2] * 
[AB] (a) . .  . . . (a) (a) (a) 














[BB] (a) . .  . . . (a) (a) (a) 
[Hp2-2] * 
[BC] (a) . .  . . . (a) (a) (a) 
[Hp2-2] * 




























0.000 0.000 3.802 1 0.051 -0.001 1.8E-6 1.000 0.999 1.000 
[Female] * 
age -0.052 0.036 2.093 1 0.148 -0.121 0.018 0.936 0.857 1.024 
[Male] * 
age (a) . . 0 . . . (a) (a) (a) 
(a)  estimates not evaluated because they are redundant. 
 
The odds ratio of outcome Y=i versus outcome Y=3 (reference category) for 
regressor values of x=a versus x=b, is 
 
, i=0, 1, 2,  
 
where x is the dummy variable vector, taking 1 in the position corresponding to 
the presence of a specific category of the specific independent categorical 
variable. 
For example, the odds ratio of outcome Y=i versus Y=3 for haptoglobin 
































The result indicates that there is no difference between the two phenotypes 
(Hp1-1, Hp2-1) as regards predisposition to obesity. 
The other odds ratios are obtained similarly, and the results are shown in 
Table 3. 
 
Table 3. Odds ratio estimates, ),( baiOR . 
*Reference category of the outcome variable is Y=3  




come Y Hp2-1 AB AC BB BC 
0 1.049     
1 1.049     Hp1-1 
2 1.015     
0  0.072 0.133 0.062 0.069 
1  0.628 0.745 0.618 0.616 AA 
2  0.757 0.885 0.748 0.746 
0  ** 1.857 0.963 0.956 
1  ** 1.187 0.985 0.981 AB 
2  ** 1.168 0.988 0.985 
0  ** ** 0.519 0.515 
1  ** ** 0.829 0.827 AC 
2  ** ** 0.846 0.843 
0  ** ** ** 0.993 
1  ** ** ** 0.997 BB 
2  ** ** ** 0.846 
** Estimates not evaluated because they are redundant. 
 
Examining Table 3, we find that: 
- The phenotype 1-1 of haptoglobin carries a small increase in risk of obesity 
relative to phenotype Hp2-1; 
- Regarding the acid phosphatase phenotypes, we find the following: 
1. AA is a protecting factor against obesity relative to the other phenotypes 
AB, AC, BB, and BC; 
2. AB is a risk factor for obesity relative to phenotype AC; 
3. AC is a protecting factor against obesity relative to the remaining 
phenotypes BB and BC; 














These results show three factors which are associated with an increased risk 
of obesity, namely: phenotype Hp2-1 of haptoglobin carries an almost 12 times 
higher probability of belonging to higher weight categories than phenotype 
Hp2-2 (reference category); phenotype AA of acid phosphatase carries an 
almost 34 times higher probability of belonging to higher weight categories than 
phenotype CC (reference category); for every increase of ten years in age, the 
risk of belonging to a higher weight category increases 7.613 times.  
The interaction between phenotype Hp2-1 and phenotype AC of acid 
phosphatase is a protecting factor against obesity ( 032.0=OR ) as is also the 
interaction between phenotype AA and the activity of this enzyme 
( 954.0=OR ). This last result suggests a question: why is phenotype AA a risk 
factor for obesity when isolated (main effect) but a protecting factor when 
associated with acid phosphatase activity? 
Considering the results given in Table 5 (namely the 95% C.I.) and the 
value of the Cox and Snell R2 (0.539), this model it is not a good model for 
prediction.  
To conclude, this work has made it possible to identify some potential risk 
factors and relationships between them for obesity, i.e., knowing the genetic and 
demographic characteristics studied here, it will be possible to develop 
preventive measures, adapted to each particular case. 
It seems important for further studies to be carried out, in order to confirm 
some of the results and to explore the potential relationship of excess weight 
and obesity with other variables. 
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